Applied DNA Sciences (APDN) Misses Q4 EPS by 18c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. LLY
5. FLG
6. META
7. FICO
8. GMAB
9. QQQ
10. TSLA

Go back to Applied DNA Sciences (APDN) Misses Q4 EPS by 18c, Revenues Miss

Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results

December 12, 2019 4:05 PM EST

Company to Hold Conference Call and Webcast Today, Thursday, December 12, 2019 at 4:30 PM ET

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic development today announced consolidated financial results for the full fiscal year and quarter ended September 30, 2019.

In fiscal 2019 total revenues increased 38%, and total operating expenses decreased by 5% as we sharpened our focus on our ability to produce linear DNA at scale for our... More